Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-29 17:45 |
AMOEBA : L'US EPA en voie d’approuver la solution de biocontrôle d’Amoéba pour …
|
French | PDF • 281.0 KB | ||
| 2022-09-29 17:45 |
AMOEBA: US EPA about to approve Amoéba’s biocontrol solution for use in agricul…
|
English | PDF • 271.2 KB | ||
| 2022-09-15 17:45 |
AMOEBA announces the issuance of the sixth tranche of 60 bonds convertible into…
|
English | PDF • 306.9 KB | ||
| 2022-09-15 17:45 |
AMOEBA annonce l’émission de la sixième tranche de 60 obligations convertibles …
|
French | PDF • 374.2 KB | ||
| 2022-09-05 18:00 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 244.9 KB | ||
| 2022-08-10 17:45 |
Amoeba: US EPA about to approve Amoeba’s biocide for use in closed cooling syst…
|
English | PDF • 259.3 KB | ||
| 2022-08-10 17:45 |
Amoéba : l'US EPA en voie d’approuver le biocide d’Amoéba pour un usage dans le…
|
French | PDF • 267.3 KB | ||
| 2022-08-03 22:50 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 245.4 KB | ||
| 2022-07-05 17:45 |
AMOEBA : Avis rectificatif - BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 390.0 KB | ||
| 2022-07-05 17:45 |
Amoeba : Report de l’émission de la 6ème tranche d’OCA
|
French | PDF • 258.8 KB | ||
| 2022-07-05 17:45 |
Amoéba: Deferral of the 6th tranche of OCAs
|
English | PDF • 247.1 KB | ||
| 2022-07-04 17:45 |
AMOEBA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 387.3 KB | ||
| 2022-07-04 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 245.4 KB | ||
| 2022-06-13 17:45 |
AMOEBA announces the issuance of the fifth tranche of 60 bonds convertible into…
|
English | PDF • 266.3 KB | ||
| 2022-06-13 17:45 |
AMOEBA annonce l’émission de la cinquième tranche de 60 obligations convertible…
|
French | PDF • 399.6 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
